跳至主要内容
临床试验/NCT06386198
NCT06386198招募中不适用

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年3月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Changes in patient experience

研究概览

简要总结

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has received a liver transplant >1 year ago
  • Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
  • Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.
  • Patient will be transferred to adult transplant team in <6 months.
  • Patient can read and write English or Spanish
  • Patient is between 18-25 years old and can provide informed consent.
  • Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

排除标准

  • Patient has significant cognitive impairment.
  • Does not meet age criteria
  • Patient is a ward of the state.
  • Non-English, non-Spanish speakers.
  • Non-US residents.

研究组 & 干预措施

Intervention

Experimental

This is a single arm pilot intervention.

干预措施: Health Advocate (Behavioral)

结局指标

主要结局

Changes in patient experience

时间窗: Baseline and 180 days

The investigators will administer a survey of patient experience at study enrollment and at the end of the intervention to assess for changes in patient experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall subjective assessment of the transplant recipient's overall health.

次要结局

  • Change in medication adherence using MLVI(Baseline and 180 days)
  • The quality of health advocate interactions with the participants, healthcare team, and community-based resources.(180 days)
  • A qualitative assessment of patient and healthcare provider satisfaction with the Health Advocate intervention.(180 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验